Menstrual Complete

Product NDC: 63868-032
11-digit product format: 638680032
Labeler code: 63868
Product ID: 63868-032_c21cc4e8-1cea-4e4b-bcec-53e89d207612
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen, Caffeine, Pyrilamine maleate
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: CHAIN DRUG MARKETING ASSOCIATION INC
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2002-04-29
Marketing end: 2027-05-31
Substance: ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE
Active strength: 500; 60; 15 mg/1; mg/1; mg/1
Pharmacologic classes: Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]
NDC exclude flag: No
Current FDA listing: Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Menstrual Complete
Brand name suffix: Maximum Strength

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ACETAMINOPHEN	500 mg/1
CAFFEINE	60 mg/1
PYRILAMINE MALEATE	15 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
362O9ITL9D	Internal UNII lookup
3G6A5W338E	Internal UNII lookup
R35D29L3ZA	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1597298	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
913d8bdb-7644-464c-b9a6-55387ff12059	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7dea7767-9f52-b60a-5435-33cb9cc28bae	Product name	4	20250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4	Product name	7	20250116
0ca83774-3f79-b837-5d6f-c210102f3bc8	Product name	6	20250114
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
2dc76302-91c0-4c35-ad78-99adfb049c4b	Product name	1	20200603
e6065d4b-5ae1-476f-a40e-f2851cbb5d2b	Product name	2	20180221
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
332e86c3-7875-ca6e-f934-2206d2b31996	Product name	1	20140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21	Product name	1	20140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508
d223c173-c39b-d764-47d4-d671d3088815	Product name	1	20140508
e01133ad-4dcd-c7f3-454b-2ff569ee160a	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63868-032-24	Menstrual CompleteMaximum Strength	1 in 1 CARTON	TABLET, FILM COATED	1		13
63868-032-24	Menstrual CompleteMaximum Strength	24 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	24		13

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63868-032-24	EA - Each	63868-032	ac599e99-e04e-423a-ab46-fd2a457669ec	1	2022-08-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ACETAMINOPHEN	ACTIVE INGREDIENT	362O9ITL9D	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
CAFFEINE	ACTIVE INGREDIENT	3G6A5W338E	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
PYRILAMINE MALEATE	ACTIVE INGREDIENT	R35D29L3ZA	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
ACETAMINOPHEN	ACTIVE MOIETY	362O9ITL9D	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
CAFFEINE	ACTIVE MOIETY	3G6A5W338E	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
PYRILAMINE	ACTIVE MOIETY	HPE317O9TL	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET [CHAIN DRUG MARKETING ASSOCIATION INC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63868-032	MENSTRUAL COMPLETE MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE) TABLET, FILM COATED [CHAIN DRUG MARKETING ASSOCIATION INC]	12	Current NDC, Legacy NDC, 2 package rows	20241024_913d8bdb-7644-464c-b9a6-55387ff12059.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 73 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
PANADOL Extra	ACETAMINOPHEN AND CAFFEINE	Haleon US Holdings LLC	e5c2d88a-d903-4ca0-b895-f27e791dfc4e	2024-02-06	Warnings	Exact identifier application number: M013
PANADOL Extra Strength	ACETAMINOPHEN	Haleon US Holdings LLC	b2fe7f47-1a2e-40ee-8f8f-38f2028dce1b	2024-02-06	Warnings	Exact identifier application number: M013
PANADOL Extra Strength	ACETAMINOPHEN	Haleon US Holdings LLC	9d384e88-5c11-4600-ac6c-a38371570138	2024-02-06	Warnings	Exact identifier application number: M013
PANADOL	ACETAMINOPHEN	Haleon US Holdings LLC	95801755-db54-4ad7-bec1-52671914f6ca	2024-02-06	Warnings	Exact identifier application number: M013
PANADOL PM	ACETAMINOPHEN AND DIPHENHYDRAMINE HCL	Haleon US Holdings LLC	01e7dddb-755c-4745-b701-edcdb6209064	2024-02-06	Warnings, Adverse reactions	Exact identifier application number: M013
PANADOL PM	ACETAMINOPHEN AND DIPHENHYDRAMINE HCL	Haleon US Holdings LLC	fe7cd1f2-9b00-4ded-99c2-8a152c71093c	2024-02-06	Warnings, Adverse reactions	Exact identifier application number: M013
Childrens Pain and Fever	ACETAMINOPHEN	AptaPharma Inc.	9064943f-836f-4853-b6f2-2c4879941eeb	2024-02-02	Warnings	Exact identifier application number: M013
Quality Choice Effervescent Pain Relief	ASPIRIN	CHAIN DRUG MARKETING ASSOCIATION, INC.	079af5d7-1be8-2a93-e063-6294a90a496d	2024-02-01	Warnings	Exact identifier application number: M013
MEDI-FIRST Non-Aspirin	ACETAMINOPHEN	Proficient Rx LP	4c84948d-3a95-4c53-8529-7e7b9d8bb6df	2024-02-01	Warnings	Exact identifier application number: M013
Pharbetol	ACETAMINOPHEN	Proficient Rx LP	9c7d65e4-df2f-47c1-a185-66aaf19aad2b	2024-02-01	Warnings	Exact identifier application number: M013
Childrens Acetaminophen	ACETAMINOPHEN	Proficient Rx LP	57e4820c-b4eb-442e-9c49-93eedfbc5e5e	2024-02-01	Warnings	Exact identifier application number: M013
good sense aspirin	ASPIRIN	Proficient Rx LP	73013074-9c6e-43c7-acde-4d9d8ed0133d	2024-02-01	Warnings	Exact identifier application number: M013
MEDIQUE APAP Extra Strength	ACETAMINOPHEN	Proficient Rx LP	c466a07f-2339-4cf5-8377-e0f109649c52	2024-02-01	Warnings	Exact identifier application number: M013
Percogesic Extra Strength	ACETAMINOPHEN AND DIPHENHYDRAMINE	Medtech Products Inc.	2c5f1140-fb83-42c9-b0b1-5e2bd69340bb	2024-02-01	Warnings	Exact identifier application number: M013
aspirin	ASPIRIN	Proficient Rx LP	3c7783a7-2b28-4968-b766-0a49dc70ce6d	2024-02-01	Warnings	Exact identifier application number: M013
Regular Strength Pain Relief	ACETAMINOPHEN	NuCare Pharmaceuticals,Inc.	102bdcde-cb90-f248-e063-6394a90aac79	2024-01-30	Warnings	Exact identifier application number: M013
Excedrin Extra Strength Headache	ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE	Haleon US Holdings LLC	61802b27-c9ec-4386-9d44-45e8b1e558b7	2024-01-28	Warnings	Exact identifier application number: M013
AGRIFEN	ACETAMINOPHEN, ASPIRIN, CAFFEINE	OPMX LLC	0fde22da-cdfc-36cc-e063-6294a90a3885	2024-01-26	Warnings	Exact identifier application number: M013
DOLODOL	ACETAMINOPHEN, ASPIRIN, CAFFEINE	OPMX LLC	e80536f1-92cc-5bb3-e053-2995a90a9540	2024-01-26	Warnings	Exact identifier application number: M013
LOW DOSE ASPIRIN	ASPIRIN	Bryant Ranch Prepack	d913d11f-c7a1-49d2-a2d3-9a29fc032806	2024-01-18	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN
3G6A5W338E	CAFFEINE	58-08-2	CAFFEINE
R35D29L3ZA	PYRILAMINE MALEATE	59-33-6	PYRILAMINE MALEATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1597298	acetaminophen 500 MG / caffeine 60 MG / pyrilamine maleate 15 MG Oral Tablet	PSN	913d8bdb-7644-464c-b9a6-55387ff12059	13
1597298	acetaminophen 500 MG / caffeine 60 MG / pyrilamine maleate 15 MG Oral Tablet	SCD	913d8bdb-7644-464c-b9a6-55387ff12059	13
1597298	APAP 500 MG / Caffeine 60 MG / Pyrilamine Maleate 15 MG Oral Tablet	SY	913d8bdb-7644-464c-b9a6-55387ff12059	13

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
63868-032-24	63868003224	1 BOTTLE, PLASTIC in 1 CARTON (63868-032-24) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC	2002-04-29	2027-05-31	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Quality Choice 44-390 Delisted	CHAIN DRUG MARKETING ASSOCIATION INC \| LNK International, Inc.	2025-10-17	HUMAN OTC DRUG LABEL	13